Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.1 CHF | -0.42% |
|
-3.53% | +39.69% |
06-18 | Switzerland's Cosmo Pharmaceuticals Receives Drug Registration Certificate for Lumeblue in China | MT |
06-03 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.69% | 1.29B | |
+52.93% | 803B | |
+40.55% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+17.13% | 244B | |
+1.39% | 226B | |
+6.24% | 164B | |
-4.79% | 155B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Transcript : Cosmo Pharmaceuticals N.V., 2020 Earnings Call, Mar 26, 2021